Schedule 13G/A: Vanguard Holds 10% of Amgen Common Stock

Rhea-AI Filing Summary

Amgen Inc: The Vanguard Group reports beneficial ownership of 53,860,795 shares of Amgen common stock, representing 10% of the class. Vanguard states it has sole dispositive power over 48,671,065 shares and shared dispositive power over 5,189,730 shares, with shared voting power for 3,134,008 shares and no sole voting power. The filing is submitted on a Schedule 13G/A and includes a certification that the holdings are in the ordinary course of business and not intended to influence control of the issuer.

Insights

Financial Analyst

TL;DR: Vanguard holds a material passive stake of 10% in Amgen, indicating significant institutional ownership without intent to influence control.

Vanguard's reported 53,860,795 shares (10%) is a sizable position that can influence liquidity and voting blocs even if held passively. The breakdown shows 48,671,065 shares under sole dispositive power, meaning Vanguard controls sales decisions for the majority of its position. The shared voting power of 3,134,008 implies some voting influence through pooled or discretionary vehicles. The certification confirms this is a passive Schedule 13G filing rather than an active 13D seeking control.

Corporate Governance Expert

TL;DR: A 10% passive stake is material for governance dynamics but this filing affirms no intent to change control.

The statement explicitly certifies the securities are held in the ordinary course of business and not for the purpose of changing control, consistent with a Schedule 13G disclosure. While Vanguard reports no sole voting power and 3,134,008 shared voting power, its substantial dispositive authority over 48,671,065 shares warrants monitoring for potential coordinated voting actions or voting agreements disclosed elsewhere. As presented, this remains a passive, material institutional holding.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 10)

Amgen Inc

(Name of Issuer)

Common Stock

(Title of Class of Securities)

031162100

(CUSIP Number)

08/29/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 031162100

1

Names of Reporting Persons

The Vanguard Group

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

PENNSYLVANIA

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 3,134,008.00
7	Sole Dispositive Power 48,671,065.00
8	Shared Dispositive Power 5,189,730.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

53,860,795.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

10 %

12

Type of Reporting Person (See Instructions)

IA

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Amgen Inc
(b)	Address of issuer's principal executive offices: 1 Amgen Center Drive, Thousand Oaks, CA, 91320
Item 2.
(a)	Name of person filing: The Vanguard Group
(b)	Address or principal business office or, if none, residence: 100 Vanguard Blvd., Malvern, PA 19355
(c)	Citizenship: PA
(d)	Title of class of securities: Common Stock
(e)	CUSIP No.: 031162100
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 53860795
(b)	Percent of class: 10 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 0
	(ii) Shared power to vote or to direct the vote: 3134008
	(iii) Sole power to dispose or to direct the disposition of: 48671065
	(iv) Shared power to dispose or to direct the disposition of: 5189730
Item 5.	Ownership of 5 Percent or Less of a Class.
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required. The Vanguard Group, Inc.'s clients, including investment companies registered under the Investment Company Act of 1940 and other managed accounts, have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities reported herein. No one other person's interest in the securities reported herein is more than 5%.
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

The Vanguard Group

Signature:	Ashley Grim
Name/Title:	Head of Global Fund Administration
Date:	09/08/2025